Fatty Liver Disease in Nordic Countries

NCT ID: NCT04340817

Last Updated: 2020-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

634 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-09-01

Study Completion Date

2026-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Alcoholic Fatty Liver Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Proteomics

Mass-spectometry proteomics

Intervention Type DIAGNOSTIC_TEST

Transcriptomics

Next generation sequencing

Intervention Type DIAGNOSTIC_TEST

Genomics

Targeted genetics

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-alcoholic fatty liver disease and
* Healthy volunteers

Exclusion Criteria

* Other liver diseases than non-alcoholic fatty liver disease
* Lack of informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Copenhagen University Hospital, Hvidovre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lise Gluud

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lise L Gluud, MD

Role: PRINCIPAL_INVESTIGATOR

Copenhagen University Hospital, Hvidovre, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gastrounit, Copenhagen University Hospital Hvidovre

Hvidovre, Capital Region Denmark, Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lise L Gluud, MD

Role: CONTACT

+45 38623862

Mikkel P Werge, MD

Role: CONTACT

+45 38623862

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lise L Gluud, MD

Role: primary

+4538621964

Mikkel P Werge, MD

Role: backup

+38620411

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Flinc07042020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lifestyle Guidance Methods in NAFLD
NCT05792488 COMPLETED NA